What is CVE-2026-129985?
Dokploy is a free, self-hostable Platform as a Service (PaaS). Prior to 0.31.1, a user-controlled schedule appName is joined into the schedule directory path and interpolated without shell quoting into commands that create the directory and write the schedule script. An authenticated user who can create or update a dokploy-server schedule can inject operating-system commands that execute with the Dokploy process privileges when the schedule is saved, including root privileges on typical installations. This issue is fixed in version 0.31.1.
The record classifies CVE-2026-129985 under weakness class CWE-77. 1 affected-product entry is recorded, across 1 vendor, listed below. The identifier was first published 1 day ago.
Severity and exploitation probability
- CVSS v4.0 base score
- 8.7 — High (derived from score)
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N - CISA KEV
- Not listed in the CISA Known Exploited Vulnerabilities catalog
- Threadlinqs priority
- 4.4/10 — a Threadlinqs composite of the CVSS base score, the EPSS percentile and public exploit availability
- Published
- 2026-11-18
Is CVE-2026-129985 being exploited?
It currently carries a trending score of 30 in the Threadlinqs vulnerability feed.
Affected products and versions
- Dokploy: dokploy
How to fix CVE-2026-129985
No vendor patch reference has been recorded for CVE-2026-129985 in the tracked sources. Follow the references below for a fix, and treat the products listed above as exposed until the vendor states otherwise.
Threat activity tracking CVE-2026-129985
No threat campaign in the Threadlinqs corpus currently references CVE-2026-129985, in its CVE list or as an indicator. The linkage is recomputed from the live corpus on every daily ingest, so this section fills in as soon as a tracked campaign cites the identifier.
Sources
Enriched from CVE.org, NVD. This product uses the NVD API but is not endorsed or certified by the NVD.